1. Yan, Xin, Tian, Dayu, Peng, Rui, Zhou, Qin, Li, Qianyin. 2022. Tetratricopeptide repeat domain 36 protects renal tubular cells from cisplatin-induced apoptosis potentially via maintaining mitochondrial homeostasis. In Tissue & cell, 76, 101749. doi:10.1016/j.tice.2022.101749. https://pubmed.ncbi.nlm.nih.gov/35176677/
2. Jing, Wei, Peng, Ruoyu, Li, Xiaogai, Duan, Yu, Jiang, Shitao. 2022. Study on the Prognostic Values of TTC36 Correlated with Immune Infiltrates and Its Methylation in Hepatocellular Carcinoma. In Journal of immunology research, 2022, 7267131. doi:10.1155/2022/7267131. https://pubmed.ncbi.nlm.nih.gov/35846428/
3. Zhou, Yuru, He, Qingling, Chen, Jihui, Gu, Yuping, Zhou, Qin. 2016. The expression patterns of Tetratricopeptide repeat domain 36 (Ttc36). In Gene expression patterns : GEP, 22, 37-45. doi:10.1016/j.gep.2016.11.001. https://pubmed.ncbi.nlm.nih.gov/27826126/
4. Yan, Xin, Peng, Rui, Ni, Yilu, Li, Qianyin, Zhou, Qin. 2021. Tetratricopeptide repeat domain 36 deficiency mitigates renal tubular injury by inhibiting TGF-β1-induced epithelial-mesenchymal transition in a mouse model of chronic kidney disease. In Genes & diseases, 9, 1716-1726. doi:10.1016/j.gendis.2021.04.005. https://pubmed.ncbi.nlm.nih.gov/36157495/
5. Wu, Min, Yuan, Keyu, Lyu, Shuzhen, Li, Yanping. 2022. Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer. In World journal of surgical oncology, 20, 214. doi:10.1186/s12957-022-02683-2. https://pubmed.ncbi.nlm.nih.gov/35751103/
智鼠故事 
